Scopio Labs gains De Novo clearance for AI bone marrow analysis software and more FDA clearances

Epitel received 510(k) clearance for two remote monitoring offerings and Curio Digital Therapeutics  received clearance for its postpartum prescription digital therapeutic.
Source: mobihealthnews - Category: Information Technology Source Type: news